SOURCE: HealthSonix Inc.

October 11, 2006 08:00 ET

New Clinical Trials Begin for AquaSonix Therapy Programs

IRVINE, CA -- (MARKET WIRE) -- October 11, 2006 -- HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) today announced it has commenced a pilot study with patients currently enrolled in aquatic fitness classes who also experience pain associated with arthritis.

Patients enrolled in the study were actively involved in recreational aqua-fit classes, but are obviously still in pain and suffering with lack of function. The participants are active and reasonably fit. The study is designed to measure the effectiveness of the AquaSonix Therapy compared to exercise alone, in reducing the pain and improving function. The trials will be conducted over an 8-week period.

AquaSonix Therapy is a breakthrough medical treatment for people with pain, reduced mobility and diminishing flexibility. It's a therapeutic water program that combines sound pressure waves with individualized low impact exercises in warm water therapy pools.

The proprietary sound pressure waves are believed to work by stimulating mechanoreceptors in the skin, which in turn communicate with the brain and block pain messages from getting through (gate control theory of pain); by creating an exercise effect in the muscles, which encourages the production and release of endorphins, the body's natural pain killers; and by increasing blood circulation.

HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) is a publicly traded medical technology company. The Company's core offerings are based on proprietary, patent pending medical technologies that use sound pressure waves to administer sub-sensory micro vibration to the human body. Precisely formatted low frequency sound pressure waves are 80% effective in treating the pain of many diseases, particularly arthritis. All treatments and products are safe, non-invasive, drug free, and have no known side effects.

More information regarding HealthSonix and its products and services can be found at: or by calling the company at 1-877-622-2121.

Note: A number of statements contained in this report are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.

Contact Information